Long-term outcome of renal glucosuria type 0: the original patient and his natural history.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 15299100)

Published in Nephrol Dial Transplant on September 01, 2004

Authors

Sabine Scholl-Bürgi1, René Santer, Jochen H H Ehrich

Author Affiliations

1: Department of Pediatrics, Medical School Hannover, Hannover, Germany. sabine.scholl@uibk.ac.at

Articles citing this

SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol (2010) 2.85

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med (2010) 1.92

Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2. Am J Physiol Cell Physiol (2010) 1.62

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am J Physiol Renal Physiol (2013) 1.29

Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol (2012) 1.10

Renal glucose transporters: novel targets for hyperglycemia management. Nat Rev Nephrol (2010) 0.98

Abnormal expression and dysfunction of novel SGLT2 mutations identified in familial renal glucosuria patients. Hum Genet (2010) 0.97

Familial renal glucosuria: a clinicogenetic study of 23 additional cases. Pediatr Nephrol (2012) 0.95

Structural selectivity of human SGLT inhibitors. Am J Physiol Cell Physiol (2011) 0.92

Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes. Diabetes Ther (2011) 0.87

Drug-induced acid-base disorders. Pediatr Nephrol (2014) 0.78

Decreased expression and function of sodium-glucose co-transporter 2 from a novel C-terminal mutation: a case report. BMC Nephrol (2016) 0.78

Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic Kidney Disease. Sci Rep (2016) 0.75

Influence of Familial Renal Glycosuria Due to Mutations in the SLC5A2 Gene on Changes in Glucose Tolerance over Time. PLoS One (2016) 0.75

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes. Vasc Health Risk Manag (2017) 0.75

The renal effects of SGLT2 inhibitors and a mini-review of the literature. Ther Adv Endocrinol Metab (2016) 0.75

LP-925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2. Pharmacol Res Perspect (2015) 0.75

Novel SLC5A2 mutation contributes to familial renal glucosuria: Abnormal expression in renal tissues. Exp Ther Med (2016) 0.75

Articles by these authors

(truncated to the top 100)

Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84

Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis (2012) 2.46

Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain (2005) 2.44

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2011) 2.34

Molecular analysis of the SGLT2 gene in patients with renal glucosuria. J Am Soc Nephrol (2003) 2.34

High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat (2005) 2.09

Glyceroluria and neonatal hemochromatosis. J Pediatr Gastroenterol Nutr (2012) 1.98

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90

Renal allograft function in matched pediatric and adult recipient pairs of the same donor. Transplantation (2004) 1.55

Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol (2010) 1.48

Urinary proteome analysis to exclude severe vesicoureteral reflux. Pediatrics (2012) 1.42

Alterations of cyclosporin A metabolism induced by mycophenolate mofetil. Pediatr Transplant (2003) 1.42

Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations. Transplantation (2002) 1.41

Renal arterial resistance index and computerized quantification of fibrosis as a combined predictive tool in chronic allograft nephropathy. Pediatr Transplant (2004) 1.39

A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet (2004) 1.38

Demography of pediatric primary care in Europe: delivery of care and training. Pediatrics (2002) 1.34

Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency. Mol Genet Metab (2007) 1.28

SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain (2007) 1.27

Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol (2006) 1.22

Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat (2007) 1.19

von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood (2002) 1.16

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion. Nephrol Dial Transplant (2008) 1.16

Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. Am J Hum Genet (2013) 1.09

The Cockcroft-Gault formula should not be used in children. Kidney Int (2005) 1.06

Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis (2013) 1.04

Hepatocerebral form of mitochondrial DNA depletion syndrome: novel MPV17 mutations. Arch Neurol (2008) 1.04

Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol (2002) 1.02

Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol (2011) 1.02

Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum Mutat (2006) 1.01

Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant (2010) 0.99

Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant (2009) 0.98

Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. Mitochondrion (2009) 0.94

Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening. J Inherit Metab Dis (2009) 0.94

3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals. Orphanet J Rare Dis (2012) 0.94

Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype. Mol Genet Metab (2011) 0.93

Renal replacement therapy in infants with chronic renal failure in the first year of life. Clin J Am Soc Nephrol (2009) 0.93

Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Nephrol Dial Transplant (2011) 0.92

Feeding patterns in breast-fed and formula-fed infants. Ann Nutr Metab (2002) 0.90

Cross-sectional observational study of 208 patients with non-classical urea cycle disorders. J Inherit Metab Dis (2013) 0.90

Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment. J Inherit Metab Dis (2014) 0.89

Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. Pediatr Nephrol (2004) 0.88

Schimke versus non-Schimke chronic kidney disease: an anthropometric approach. Pediatrics (2006) 0.88

Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial. Pediatr Nephrol (2008) 0.87

Management of regional citrate anticoagulation in pediatric high-flux dialysis: activated coagulation time versus post-filter ionized calcium. Pediatr Nephrol (2010) 0.87

Nephrolithiasis in a child with glucose-galactose malabsorption. Pediatr Nephrol (2003) 0.87

Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol (2009) 0.87

Lectures based on cardinal symptoms in undergraduate medicine - effects of evaluation-based interventions on teaching large groups. GMS Z Med Ausbild (2011) 0.87

Schimke-immuno-osseous dysplasia: new mutation with weak genotype-phenotype correlation in siblings. Am J Med Genet A (2005) 0.86

Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr Nephrol (2013) 0.86

Effect of kidney disease on glucose handling (including genetic defects). Kidney Int Suppl (2011) 0.86

Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol (2006) 0.86

Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding. Nephrol Dial Transplant (2010) 0.86

Computer-assisted quantification of fibrosis in chronic allograft nephropaty by picosirius red-staining: a new tool for predicting long-term graft function. Transplantation (2003) 0.85

Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'? Nephrol Dial Transplant (2005) 0.85

A genetic polymorphism in the coding region of the gastric intrinsic factor gene (GIF) is associated with congenital intrinsic factor deficiency. Hum Mutat (2004) 0.85

Prematurity, small for gestational age and perinatal parameters in children with congenital, hereditary and acquired chronic kidney disease. Nephrol Dial Transplant (2010) 0.84

SMARCAL1 mutations: a cause of prepubertal idiopathic steroid-resistant nephrotic syndrome. Pediatr Res (2009) 0.84

Elements of diabetic nephropathy in a patient with GLUT 2 deficiency. Mol Genet Metab (2005) 0.84

Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis. JIMD Rep (2014) 0.84

Improved outcome with immunosuppressive monotherapy after renal transplantation in Schimke-immuno-osseous dysplasia. Pediatr Transplant (2008) 0.84

Analysis of mRNA transcripts improves the success rate of molecular genetic testing in OTC deficiency. Mol Genet Metab (2008) 0.83

Single centre experience with basiliximab in paediatric renal transplantation. Nephrol Dial Transplant (2002) 0.83

Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: a single-center experience and a review of the literature. Liver Transpl (2014) 0.83

Aetiology and outcome of acute and chronic renal failure in infants. Nephrol Dial Transplant (2008) 0.83

Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. Kidney Int (2003) 0.83

Diagnostic pathways for exclusion and diagnosis of kidney diseases. Clin Lab (2012) 0.82

Young for young! Mandatory age-matched exchange of paediatric kidneys. Pediatr Nephrol (2006) 0.81

High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: implications for the pathophysiology of phenylketonuria. Neurobiol Dis (2008) 0.81

Elevated asymmetric dimethylarginine (ADMA) and inverse correlation between circulating ADMA and glomerular filtration rate in children with sporadic focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant (2008) 0.81

Renal arterial resistance index. N Engl J Med (2003) 0.81

Thirty years of the Union of National European Paediatric Societies and Associations (UNEPSA). Eur J Pediatr (2006) 0.81

Fanconi-Bickel syndrome and fertility. Am J Med Genet A (2011) 0.80

Growth hormone treatment of renal growth failure during infancy and early childhood. Pediatr Nephrol (2009) 0.80

Early kidney transplantation improves neurocognitive outcome in patients with severe congenital chronic kidney disease. Transpl Int (2015) 0.79

Quantitative gene expression of TGF-beta1, IL-10, TNF-alpha and Fas Ligand in renal cortex and medulla. Nephrol Dial Transplant (2002) 0.79

Haemorrhagic complications in paediatric dialysis-dependent acute kidney injury: Incidence and impact on outcome. Nephrol Dial Transplant (2009) 0.79

Transient pseudo-hypertriglyceridemia: a useful biochemical marker of fructose-1,6-bisphosphatase deficiency. Eur J Pediatr (2013) 0.78

Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation. Pediatr Nephrol (2004) 0.78

Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany. JIMD Rep (2015) 0.78

Evaluation of electrospray-tandem mass spectrometry for the detection of phenylketonuria and other rare disorders. Mol Nutr Food Res (2006) 0.78

Reliability of different expert systems for profiling proteinuria in children with kidney diseases. Pediatr Nephrol (2007) 0.78

Estimation of glomerular filtration rate in liver-transplanted children: comparison of simplified procedures using 51Cr-EDTA and endogenous markers with Sapirstein's method as a reference standard. Pediatr Transplant (2010) 0.77

Effective treatment of anemia in pediatric kidney transplant recipients with methoxy polyethylene glycol-epoetin beta. Pediatr Transplant (2011) 0.77

Mitochondrial function in schimke-immunoosseous dysplasia. Metab Brain Dis (2005) 0.76

Reversal of loss of glomerular filtration rate in children with transplant nephropathy after switch to everolimus and low-dose cyclosporine A. Pediatr Transplant (2007) 0.76

Improved gastrointestinal symptom burden after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in kidney transplanted children. Pediatr Transplant (2008) 0.76

Urinary alpha-ketoglutarate is elevated in patients with hyperinsulinism-hyperammonemia syndrome. Clin Chim Acta (2004) 0.76

Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy. Transplantation (2003) 0.76

A child with night blindness: preventing serious symptoms of Refsum disease. J Child Neurol (2011) 0.75

Re-establishment of the ERA-EDTA Registry. Pediatr Nephrol (2003) 0.75

Cysteamine dose regimen. Pediatr Nephrol (2006) 0.75

End-stage renal disease due to ARPKD in the first months of life: transplantation or dialysis?--two case reports. Pediatr Transplant (2009) 0.75

SPF 50 for organ transplant patients--over the top? Nephrol Dial Transplant (2009) 0.75

Cyclosporin A-induced remission of primary membranous glomerulonephritis in a child. Nephrol Dial Transplant (2004) 0.75

Successful pregnancy in the patient with Fanconi-Bickel syndrome undergoing daily hemodialysis. Am J Med Genet A (2011) 0.75

The founding and early history of the European Society for Paediatric Nephrology (ESPN). Pediatr Nephrol (2007) 0.75

Glucose transporter-1 (GLUT1) deficiency syndrome: diagnosis and treatment in late childhood. Neuropediatrics (2012) 0.75

Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature. J Pediatr Endocrinol Metab (2016) 0.75

Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A. Pediatr Nephrol (2007) 0.75

ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B. Xenotransplantation (2006) 0.75